Market Research Future (MRFR) has published a research report about the global non-sterile
compounding pharmacy market that predicts growth for this market at a 2.65% CAGR
(Compound Annual Growth Rate) between 2017 and 2023.
Request Sample Copy:
The key factors driving the global non-sterile compounding pharmacy market growth include
the growing demand for anti-aging products (especially in Europe and the USA), exposure to
harmful radiation, hereditary reasons & genetic mutations (abnormal changes), and increasing
geriatric population. Other major factors aiding the market growth include government
initiatives favorable to the market, rising per capita income in developed countries (and in
some developing countries), the increasing prevalence of chronic diseases, and the rising need
for customized medicine. However, high prices, long approval time for clinical trials, and strict
regulations governing the manufacturing of the compounded product can hinder the market
The Global Non-Sterile Compounding Pharmacy Market has been segmented on the basis of
application, end user, product, and lastly, region. The application-based segmentation
segments this market into hormone replacement therapy and pain medication. Based on the
end users, the market has been segmented into compounding pharmacies, hospitals, and
others. By product, the market has been segmented into otologic/nasal medication, oral
medication, topical medication, and others.
The regional segmentation of the Global Non-Sterile Compounding Pharmacy Market segments
the market into North America and Europe.
North America is the biggest regional market because of the presence of the USA, which is large
enough to be the largest regional market in the world. The USA is equipped with most
advanced medical facilities, high level of research and development (R&D), the increasing
prevalence of chronic diseases, rising demand for customized medicine